7-Chlorotryptamine (7-chloro-T, 7-CT, or 7-Cl-T; code name PAL-532) is a serotonin receptor agonist and monoamine releasing agent (MRA) of the tryptamine family.[1] It is a pale yellow solid.[2] It is a full agonist of the serotonin 5-HT2A receptor, with an EC50Tooltip half-maximal effective concentration of 18.8 nM and an EmaxTooltip maximal efficacy of 102%.[1] In addition, it is a serotonin releasing agent (SRA), with EC50 values of 8.03 nM for serotonin, 656 nM for norepinephrine, and 1,330 nM for dopamine in rat brain synaptosomes.[1] The drug is one of the most potent SRAs in vitro known, after 6-fluorotryptamine (6-FT) and naphthylaminopropane (NAP; PAL-287).[1] 7-CT was first described in the scientific literature by 2014.[1]

See also

References

  1. ^ a b c d e Blough BE, Landavazo A, Partilla JS, Decker AM, Page KM, Baumann MH, et al. (October 2014). "Alpha-ethyltryptamines as dual dopamine-serotonin releasers". Bioorg Med Chem Lett. 24 (19): 4754–4758. doi:10.1016/j.bmcl.2014.07.062. PMC 4211607. PMID 25193229.
  2. ^ Nicolaou KC, Krasovskiy A, Majumder U, Trépanier VE, Chen DY (March 2009). "New synthetic technologies for the construction of heterocycles and tryptamines". Journal of the American Chemical Society. 131 (10): 3690–3699 (S28). Bibcode:2009JAChS.131.3690N. doi:10.1021/ja808692j. PMID 19243142.


No tags for this post.